Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Journal Title: Archives of Hepatitis Research - Year 2017, Vol 3, Issue 1
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of this disease ranges from steatosis to hepatitis and finally cirrhosis and hepatocellular carcinoma. NAFLD pathogenesis is not completely understood but various risk factors like obesity, insulin resistance, and metabolic syndromes have been identified. With the rapid increase in obesity and diabetes during the past decade, the incidence of NAFLD is on the rise and is predicted to become the most common indication for liver transplantation in the future.
Authors and Affiliations
Singh Sukhpreet, Kharbanda Kusum K
Keywords
Related Articles
- EP ID EP559401
- DOI 10.17352/ahr.000014
- Views 39
- Downloads 0
Accidentally discovered Portal Vein Thrombosis before Splenectomy due to Hypersplenism - The role of Thrombogenic Genes Polymorphisms
Portal vein thrombosis in patients with liver cirrhosis may be due neoplastic growth invading portal vein or due to non-neoplastic causes. The indications for treating PVT in cirrhotic individuals are difficult to be est...
Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health c...
Vitamin K: A potential Liver Cancer treatment way
A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K d...
Hepatitis E: Diagnostic and Therapeutic Challenges
HEV infection may be symptomatic or asymptomatic that has affected about one-third of world population with a case fatality rate of 1-2%, including 20-30% of infected pregnant women [3-5]. Though inherently hepatotropic...
Active Navigation in a Hepatitis B Program: Screening, Vaccination and Patient Assistance for Asian Americans in Michigan
Background: Hepatitis B (HBV) is one of the greatest health disparities among Asian Americans. A team of volunteers in Southeast Michigan has studied HBV among Asian Americans in Michigan for 10 years. The study looked a...